Mounting evidence supports the importance of hormonal fluctuations in temporomandibular disorder (TMD) pain among women. Stabilizing influential hormones or having a plan and skills for coping with hormonally related increases in TMD pain, therefore, may be beneficial for women with TMD pain. This randomized clinical trial evaluated the short-and long-term efficacy of 3 interventions for women with TMD pain: (1) dental hygienist-delivered pain self-management training (SMT; n = 59); (2) the same dental hygienist-delivered pain self-management training, but with a focus on menstrual cycle-related changes in pain and other symptoms (targeted SMT, or TSMT; n = 55); and (3) continuous oral contraceptive therapy (6-month trial) aimed at stabilizing hormones believed to be influential in TMD pain (COCT; n = 57). Study participants completed outcome (pain, activity interference, depression) and process (pain beliefs, catastrophizing, coping effectiveness) measures before randomization, and 6 and 12 months later. Intent-to-treat analyses supported the benefits of the SMT and TSMT interventions relative to COCT. Targeting the self-management treatment to menstrual cycle-related symptoms did not increase the treatment's efficacy. The benefits of the self-management interventions relative to COCT for pain and activity interference were statistically significant at 12 months, but not at 6 months, whereas the benefits for the process measures generally were apparent at both time points. COCT was associated with multiple adverse events (none serious). The study provides further support for long-term benefits of a safe, lowintensity (2 in-person sessions and 6 brief telephone contacts), dental hygienist-delivered self-management treatment for TMD pain. Ó
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Introduction
Pain associated with temporomandibular disorders (TMD) is common, particularly among women, and frequently associated with activity interference and psychological distress [39] . Treatments are diverse and include various medications, occlusal appliances, surgery, and cognitive-behavioral therapies (CBT) [31] . In addition, we have demonstrated the efficacy of a dental hygienist-delivered self-management intervention [11] .
Previous work by our group has also contributed to the accumulating evidence concerning the importance of hormonal fluctuations in TMD pain. We have shown that TMD pain varies systematically across the menstrual cycle, with highest pain during menses and the late luteal phase, times characterized by low or rapidly falling estradiol levels in normally cycling women and withdrawal of synthetic estrogen in women on oral contraceptives (OCs) [29] . In ovulating women, there is also a secondary pain peak around the time of ovulation, when estradiol levels fluctuate greatly. Laboratory studies have confirmed estradiol's role as a modulator of facial pain [43] , and clinical studies have found increased occurrence of headaches, a common comorbidity of TMD pain, during menses [30] . We therefore hypothesized that self-management interventions for women with TMD pain would be enhanced by attention to, and planning for, cyclic symptom changes.
Another option for reducing TMD pain increases associated with hormonal fluctuations might be continuous OC therapy (COCT). Women on standard OC regimens (hormone pills for 21 days fol-
